| 764268 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
564 Single-cell transcriptomic analysis of immune compartments following combination immunotherapy treatment in poorly immunogenic tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.564 |
Cui Ang, Moynihan Kelly, Li Shuqiang, Wang Chensu, Southard Jackson, Hacohen Nir, Irvine Darrell |
| 764267 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
563 ICT01, an anti-BTN3A mAb, and NL-201, an alpha-independent IL-2/IL-15 agonist, combine to elicit a potent anti-tumor response by synergistically stimulating Vg9Vd2 T cell activation and proliferation |
2021-11-01 |
10.1136/jitc-2021-sitc2021.563 |
Gassart Aude De, Brune Patrick, Mairesse Maelle, Agaugué Sophie, Swanson Ryan, Madakamutil Loui, Walkey Carl, Frohna Paul |
| 764266 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
562 Real-world assessment of current treatment patterns and clinical outcomes among patients with EGFR and ALK wild type non-small cell lung cancer (NSCLC) in the US |
2021-11-01 |
10.1136/jitc-2021-sitc2021.562 |
Bazhenova Lyudmila, Kish Jonathan, Cai Beilei, Caro Nydia, Feinberg Bruce |
| 764265 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
224 M2 macrophage-mediated immune suppression of chimeric antigen receptor T cells via PD-L1 signaling in prostate cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.224 |
Yamaguchi Yukiko, Gibson Jackson, Ou Kevin, Priceman Saul |
| 764264 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
222 Genetic reprogramming of merkel cell carcinoma and melanoma leads to increased MHC-I expression and antitumor immune activation in vitro and in vivo |
2021-11-01 |
10.1136/jitc-2021-sitc2021.222 |
Luly Kathryn, Green Jordan, Tzeng Stephany, Sunshine Joel |
| 764263 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
218 Autologous glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor protect against tumor challenge and generate T cell anti-tumor responses |
2021-11-01 |
10.1136/jitc-2021-sitc2021.218 |
Zilberberg Jenny, Zellander Amelia, Kirby Kenneth, Uhl Christopher, Cultrara Christopher, Scott Charles, Andrews David, Exley Mark |
| 764262 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
217 Cytotoxicity of nicotinamide enhanced natural killer cells GDA201 is based on metabolic modulation as demonstrated by artificial intelligence assisted analysis of NK cell transcriptome and metabolome |
2021-11-01 |
10.1136/jitc-2021-sitc2021.217 |
Yackoubov Dima, Pato Aviad, Rifman Julia, Cohen Sherri, Hailu Astar, Brycman Nurit, Berhani-Zipori Orit, Edri Avishay, Buhandler Boaz, Shahor Moshe, Dinowitz Nathan, David Amram Ben, Izraeli Avi, Chalifa-Caspi Vered, Levin Liron, Rabinowitz Joshua, Lu Wenyun, Lodie Tracey, Adams Julian, Geffen Yona |
| 764261 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
216 Multiplex base editing of NK cell to enhance cancer immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.216 |
Wang Minjing, Kluesner Mitchell, Vázquez Patricia Claudio, Webber Beau, Moriarity Branden |
| 764260 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
215 Tissue-resident natural killer cells resembling intraepithelial ILC1 have potent anti-tumor activity in human head and neck cancer and represent a novel class of effector cells for immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.215 |
Shin June, Horowitz Nina, Tran Quan, Chen Chen, Moreno-Nieves Uriel, Tay Joshua, Saumyaa Saumyaa, Sunwoo John |
| 764259 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
213 AB-X integrated circuit T cells demonstrate improved potency, expansion, and specificity compared to MSLN CAR T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.213 |
Santoro Stephen, Cooper Aaron, Bezman Natalie, Feng Jun, Chawla Kanika, Williams Jaspar, Gagnon John, Hall Jason, Polyak Dina, Boroughs Angela, Nguyen Michelle, Mohanty Suchismita, Litterman Adam, Granja Jeff, DeTomaso David, Zheng Grace, Smith Jenessa, LeFace Drake, Mikkelsen Tarjei, Jun Susie |
